药物洗脱微球经动脉化疗栓塞治疗肝细胞癌疗效的预测因素
研究纳入2015年1月至7月接受药物洗脱微球经动脉化疗栓塞(DEB-TACE)治疗的25例肝细胞癌患者共49个靶病灶,依据肝癌疗效评价标准在术后1-4个月动态CT上评估疗效。靶病灶客观缓解(TE3/4)率为63.3%(31/49),多因素分析显示肿瘤大小(OR 8.60,95%CI 1.87-62.8)和肿瘤位置(OR 12.2,95%CI 2.12-129.8)与疗效显著相关。
要点
- 靶病灶客观缓解(TE3/4)率为63.3%(31/49),患者水平完全缓解/部分缓解为40%(10/25)。
- 多因素分析显示肿瘤大小(OR 8.60,95%CI 1.87-62.8)和肿瘤位置(OR 12.2,95%CI 2.12-129.8)与疗效显著相关。
- 单因素分析中较大尺寸(≥2 cm)为客观缓解的预测因素(p=0.029),肝内侧叶(4段)或尾状叶(1段)位置提示疗效差(TE1/2)但未达统计学显著(p=0.051)。
核心结论
- 靶病灶的短期疗效与肿瘤大小和位置相关。
研究设计与样本
- 回顾性收集2015年1月至2015年7月接受DEB-TACE治疗的25例肝细胞癌患者(49个靶病灶)的肿瘤变量和血管造影数据;术后1-4个月动态CT依据肝癌疗效评价标准评估疗效,p<0.05为显著。
诊断标准与关键数值
- 靶病灶客观缓解(TE3/4)率为63.3%(31/49)。
- 患者水平完全缓解/部分缓解为40%(10/25)。
- 单因素分析:较大尺寸(≥2 cm)为客观缓解的预测因素(p=0.029)。
- 单因素分析:肝内侧叶(4段)或尾状叶(1段)位置提示疗效差(TE1/2),但未达统计学显著(p=0.051)。
- 多因素分析:肿瘤大小(OR 8.60,95%CI 1.87-62.8)和肿瘤位置(OR 12.2,95%CI 2.12-129.8)为与疗效显著相关的因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIMS: To identify predictors of a therapeutic effect after transarterial chemoembolisation using drug-eluting beads (DEB-TACE) for hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Between January 2015 and July 2015, tumour variables and angiographic data were collected for 25 patients (49 target lesions) after they had undergone the DEB-TACE procedure for HCC. The therapeutic effect was evaluated according to the Response Evaluation Criteria in Cancer of the Liver at follow-up dynamic computed tomography (CT) performed within 1-4 months after the procedure. A p<0.05 was considered significant.
RESULTS: On a target lesion basis, the objective response (TE3/4) rate was 63.3% (31 of 49). On univariate analysis, larger size (≥2 cm) was a predictor of an objective response (p=0.029). The tumour location of the medial (segment 4) or caudate (segment 1) lobe also indicated a poor therapeutic effect (TE1/2), but not at the level of significance (p=0.051). Multivariate analysis identified tumour size (odds ratio, 8.60; 95% confidence interval, 1.87-62.8) and tumour location (odds ratio, 12.2; 95% confidence interval, 2.12-129.8) as significant factors associated with a therapeutic effect. On a patient basis, 10 of 25 (40%) patients showed complete response/partial response. There were no significant differences between complete response/partial response and stable disease/progressive disease regarding age, gender, tumour markers, history of previous treatment, Child-Pugh class, T-stage, or Barcelona Clinic Liver Cancer Staging.
CONCLUSION: A short-term therapeutic effect was associated with tumour size and location on a target lesion basis.
引用
- Asayama Y, Okamoto D, Ushijima Y, et al. Predictors of therapeutic effect of transarterial chemoembolisation using drug-eluting beads for hepatocellular carcinoma. Clin Radiol. 2017. PMID: 28442142. doi:10.1016/j.crad.2017.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。